Global well‐being: rated by participants · children and young people with JIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global well‐being: rated by participants · children and young people with JIA
1 finding from 1 review
Global well‐being: rated by participants · children and young people with JIA
Methotrexate showed no clear difference in participant global assessment of well‐being(up to 6 months) compared with placebo (low certainty).
1 finding from 1 review
Child and family satisfaction with, and perceptions of, care and service delivery Family Experiences With Coordination of Care (FECC) survey (higher scores = better) Consumer Assessment of Healthcare Providers and Systems (CAHPS) (higher scores = ... · children with medical complexity
1 finding from 1 review
Cognitive function · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · adults with primary progressive aphasia (PPA)
1 finding from 1 review
Cognitive function · adults with primary progressive aphasia (PPA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · adults with primary progressive aphasia (PPA)
1 finding from 1 review
Quality of life assessments at 3 months or later (higher is favored) · people with primary macula‐involving rhegmatogenous retinal detachments
It is very uncertain whether face‐down positioning changes quality of life assessments at 3 months or later (higher is favored) compared with other positioning (very low certainty).
1 finding from 1 review
Improvement in occlusion (Peer Assessment Rating (PAR) or other validated scale) · Adolescents and adults with malocclusion undergoing orthodontic treatment with fixed or removable appliances
1 finding from 1 review
Woodhouse 2015 (81 participants, 22 dropouts): PAR reduction intervention median 28.0 (IQR 21.0-38.0), control median 29.0 (IQR 24.0-31.0), placebo median 27.0 (IQR 20.0-35.0); percentage improvement medians 88.9 /…
1 study · 59 participants
GRADE not reported
Closure of macular hole · participants with idiopathic macular hole
Face‐down positioning or posturing showed no clear difference in macular hole closure (anatomical assessment) compared with no face‐down positioning or posturing after macular hole surgery (low certainty).
1 finding from 1 review
Postoperative nerve compression injury (clinical assessment) · participants with idiopathic macular hole
1 finding from 1 review
POP‐Q assessment Total Vaginal Length (TVL) · women with apical uterine prolapse
1 finding from 1 review
Intervention not reported
Breast cancer stage at the time of presentation: defined as the proportion of women with breast cancer diagnosed at early stage (stage 0, I, II) Time of outcome assessment: 3 years to 20 years Method of measurement: CBE · health workers
The intervention may leads to higher breast cancer stage at the time of presentation: defined as the… (low certainty).
1 finding from 1 review
Intervention not reported
Breast cancer stage at the time of presentation: defined as the proportion of women with breast cancer diagnosed at late stage (stage III, IV) Time of outcome assessment: 3 years to 20 years Method of measurement: CBE · health workers
The intervention may leads to lower breast cancer stage at the time of presentation: defined as the… (low certainty).
1 finding from 1 review
Intervention not reported
Accuracy of health worker‐performed CBE Time of outcome assessment: 2 years to 20 years Method of measurement: Sensitivity, specificity and positive predictive value · health workers
1 finding from 1 review
Intervention not reported
CBE coverage Time of outcome assessment: 20 years Method of measurement: active surveillance · health workers
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Moderate
Intervention not reported
Breast cancer mortality: defined as deaths among women who received a diagnosis of breast cancer Time of outcome assessment: 3 years to 20 years Method of measurement: death registration offices, hospital records, and house visits · health workers
It is very uncertain whether the intervention changes breast cancer mortality: defined as deaths among women who received… (very low certainty).
1 finding from 1 review
Intervention not reported
Pain intensity measured on CHQ (0‐100; 0 = worse pain), and VAS (0 to 100; 0 = no pain) Postintervention: first assessment after end of treatment; no later than 3 months · children and adolescents aged 4 years to 18 years, with chronic musculoskeletal pain
1 finding from 1 review